NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 63629-8784-01 — TRIAMCINOLONE ACETONIDE 0.025 % TOPICAL CREAMAI (37 hospitals, 25,554–26,418 samples)
• NDC 09991-2052-00 — Collagenase topical ointment (250 units per gram)AI (22 hospitals, 25,554–26,418 samples)
• NDC 24357-0701-07 — Lidocaine 4% topical dressing kitAI (283 hospitals, 25,496–26,414 samples)
• NDC 00003-0894-31 — Apixaban 5 mg tabletsAI (1064 hospitals, 25,243–26,404 samples)
• NDC 00641-6147-10 — Sterile water for injectionAI (111 hospitals, 26,215–26,404 samples)
• NDC 00008-4001-01 — Pantoprazole 40 mg intravenous injectionAI (203 hospitals, 25,254–26,397 samples)
• NDC 00641-6147-01 — Sterile water for injectionAI (182 hospitals, 26,214–26,394 samples)
• NDC 63323-0185-08 — Sterile water for injectionAI (195 hospitals, 26,214–26,394 samples)
• NDC 65219-0187-10 — Sterile water for injection, 100 mLAI (71 hospitals, 26,214–26,394 samples)
• NDC 63323-0185-50 — Sterile water for diluting injectable medicationAI (234 hospitals, 26,214–26,394 samples)
• NDC 65219-0187-01 — Sterile water for injectionAI (140 hospitals, 26,214–26,394 samples)
• NDC 00517-3010-25 — Sterile water for injectionAI (101 hospitals, 26,214–26,394 samples)
• NDC 00264-7850-10 — Sterile preservative-free water solutionAI (153 hospitals, 26,177–26,384 samples)
• NDC 00338-1145-03 — Parenteral nutrition solution with amino acids and dextroseAI (167 hospitals, 26,242–26,377 samples)
• NDC 00006-4827-00 — Chickenpox vaccine (live, preservative-free)AI (756 hospitals, 25,623–26,370 samples)
• NDC 70199-0026-11 — Vitamin A palmitate injection solution, 50,000 units per mLAI (359 hospitals, 25,619–26,366 samples)
• NDC 00093-0053-01 — buspirone 5 mg tabletAI (476 hospitals, 25,696–26,362 samples)
• NDC 00574-4031-10 — Tobramycin and dexamethasone eye dropsAI (40 hospitals, 25,453–26,362 samples)
• NDC 63629-8664-01 — HALOBETASOL PROPIONATE 0.05 % TOPICAL OINTMENTAI (25 hospitals, 25,560–26,361 samples)
• NDC 72611-0749-10 — Midazolam 5 mg/mL injectionAI (223 hospitals, 23,630–26,348 samples)
• NDC 00338-0048-03 — sodium chloride 0.9 % irrigation solutionAI (404 hospitals, 25,777–26,344 samples)
• NDC 72078-0034-00 — Remifentanil injection vialAI (230 hospitals, 25,470–26,343 samples)
• NDC 46287-0006-60 — Sodium polystyrene sulfonate oral suspensionAI (1126 hospitals, 25,674–26,340 samples)
• NDC 24208-0342-05 — Desmopressin nasal spray, 5 mL bottleAI (616 hospitals, 25,421–26,339 samples)
• NDC 00121-0581-04 — Haloperidol oral liquid concentrate, 2 mg/mLAI (475 hospitals, 25,817–26,339 samples)
• NDC 63323-0185-00 — Sterile water for injectionAI (101 hospitals, 26,188–26,332 samples)
• NDC 16714-0782-02 — CLOBETASOL 0.05 % TOPICAL OINTMENTAI (77 hospitals, 25,545–26,328 samples)
• NDC 00591-2070-26 — Lidocaine-prilocaine numbing creamAI (75 hospitals, 25,545–26,328 samples)
• NDC 51293-0838-85 — OLOPATADINE 0.1 % EYE DROPSAI (67 hospitals, 25,544–26,318 samples)
• NDC 17478-0209-11 — KETOROLAC 0.5 % EYE DROPSAI (69 hospitals, 25,544–26,318 samples)
• NDC 60758-0018-05 — SULFACETAMIDE SODIUM 10 % EYE DROPSAI (125 hospitals, 25,544–26,318 samples)
• NDC 69238-1373-02 — Tobramycin and dexamethasone eye dropsAI (78 hospitals, 25,544–26,318 samples)
• NDC 45802-0026-83 — Azelastine nasal sprayAI (32 hospitals, 25,544–26,318 samples)
• NDC 17478-0097-10 — CYCLOPENTOLATE 2 % EYE DROPSAI (88 hospitals, 25,544–26,318 samples)
• NDC 16477-0502-56 — Balsam Peru and castor oil ointmentAI (83 hospitals, 25,544–26,318 samples)
• NDC 00168-0309-15 — DESONIDE 0.05 % TOPICAL OINTMENTAI (72 hospitals, 25,544–26,318 samples)
• NDC 00781-7080-35 — metroNIDAZOLE 1 % topical gelAI (125 hospitals, 25,544–26,318 samples)
• NDC 00338-0520-13 — Plant-based (soy) fat emulsion, 30% IVAI (72 hospitals, 25,544–26,318 samples)
• NDC 16714-0974-02 — MOMETASONE 0.1 % TOPICAL CREAMAI (22 hospitals, 25,544–26,318 samples)
• NDC 38779-0068-01 — Citric acid powder (bulk)AI (21 hospitals, 25,544–26,318 samples)
• NDC 82260-0819-05 — Timolol eye gel forming solutionAI (85 hospitals, 25,502–26,312 samples)
• NDC 62756-0129-40 — Pantoprazole 40 mg IV injectionAI (220 hospitals, 25,401–26,310 samples)
• NDC 65162-0691-79 — Ondansetron oral liquid 4 mg per 5 mLAI (462 hospitals, 21,796–26,296 samples)
• NDC 00009-0433-04 — Absorbable gelatin sponge powderAI (216 hospitals, 25,404–26,295 samples)
• NDC 70004-0810-12 — Phenylephrine IV syringe, 100 mcg/mLAI (198 hospitals, 25,128–26,289 samples)
• NDC 00378-3352-16 — Estradiol 0.1 mg/24hr weekly transdermal patchAI (247 hospitals, 25,359–26,268 samples)
• NDC 68180-0214-60 — Cyclosporine eye drops in single-use dropper vialsAI (100 hospitals, 25,520–26,267 samples)
• NDC 00409-2304-01 — Fenoldopam IV solution for blood pressureAI (104 hospitals, 26,132–26,249 samples)
• NDC 00264-7802-00 — Half-strength saline IV bolus, up to 50 mLAI (250 hospitals, 25,644–26,238 samples)
• NDC 63323-0412-02 — Midazolam injection, 10 mg per 2 mL vialAI (295 hospitals, 23,279–26,231 samples)